info-atbvac > Actualités Scientifiques > Antibiothérapie > Impact of systematic whole-body 18F-fluorodeoxyglucose PET/CT on the management of patients suspected of infective endocarditis.

Impact of systematic whole-body 18F-fluorodeoxyglucose PET/CT on the management of patients suspected of infective endocarditis.

Impact of systematic whole-body 18F-fluorodeoxyglucose PET/CT on the management of patients suspected of infective endocarditis: the prospective multicenter TEPvENDO study.

  • Xavier Duval et al.
  • Rédigé par : Dr Jean-Pierre Bru
18F-FDG-PET/CT has become one of the tools for the diagnosis of Infectious endocarditis (IE), but its impact on patients management had not been properly evaluated. The aim of this multicenter prospective study was to assess both diagnostic and patients’ management modifications induced by 18F-FDG-PET/CT using a qualitative reading of perivalvular uptake in patients suspected of NV IE or PV IE...
Ce contenu est à destination des professionnels de santé. Merci de vous identifier.
This content is intended for healthcare professionals. Thank you for identifying yourself.

Déjà inscrit / Already registered ?

Créer un compte / Create an account

Créer un compte ne prend que quelques minutes et vous permettra d'accèder à l'ensemble des contenus du site.
Creating an account takes only instant and will allow you to access all the content of the website.

Inscription / Registration